
Hosted by Raman Sehgal · EN
Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization.
Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist consulting firms. Our host Raman is an entrepreneur, investor, bestselling author, speaker and long time industry insider.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Julian Casciano, President & CEO at eMAX Health. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Julian, covering: How a family tragedy led him into the healthcare and pharmaceutical world. Why corporate life was not for him, but the valuable lessons he learned during his time at KPMG. The turbulent journey with a venture capital partner that ultimately led to an IPO and a successful first exit. How a relentless drive to become truly technology enabled has resulted in sixty percent of company revenue now coming from tech driven solutions. What led him to partner with private equity to accelerate investment in a game changing technology platform. Why the future of the sector is unfolding at speed right in front of us, and why now is the time to jump on board. As Chairman and Chief Executive Officer, Julian leads eMAX Health’s mission to modernize market access and patient services for pharmaceutical and biotech innovators. With a background in technology enabled pharmaceutical services, commercialization strategy, patient services, and entrepreneurship, he has built the organisation into a trusted partner for navigating the complexity of rapidly evolving medical and commercial programs. Most recently, Julian spearheaded the launch of MAVA®, a proprietary digital platform delivering rapid stakeholder insights and pricing guidance powered by real time data and AI. He also architected eMAX Health’s proprietary patient services case management system, HealthPACER®. Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Clement Fourny, SVP of Commercial at SmartLabs. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Clement, covering: His journey of exploring options and opportunities, which led him to the life sciences space at just the right time Why modular labs and manufacturing suites as a service could provide a de-risked and cost-effective solution to those looking to conserve cash How the SmartLabs turnkey offering enables scientists to focus on the science and not infrastructure The value of building a collaborative ecosystem and community to harness more innovation Clement has a 12-year diverse experience in the Healthcare / Life Sciences industry. Before joining SmartLabs, Clement spent his career at GE and Danaher where he built a track record of strong achievements and execution in sales, commercial operations and operational finance, mobilizing high-performing cross-functional teams to deliver sustainable growth and drive company goals. In his prior role at Cytiva (previously known as GE Life Sciences), Clement was responsible for strategically supporting the global commercial organization of 3,000 associates with best-in-class sales operations services. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.